Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EA05	ICLUSIG	B	Ponatinib - 15mg	15mg	Tablet, film coated	103,555,839 L.L
L01EA05	ICLUSIG	B	Ponatinib - 45mg	45mg	Tablet, film coated	207,092,651 L.L
N05CF04	INDUCTAL	G	Eszopiclone - 2mg	2mg	Tablet, film coated	1,411,035 L.L
N05CF04	INDUCTAL	G	Eszopiclone - 3mg	3mg	Tablet, film coated	1,693,242 L.L
C09CA04	IBECARD 150- IPS	G	Irbesartan - 150mg	150mg	Tablet, film coated	564,414 L.L
C09CA04	IRBAVEL 150	G	Irbesartan - 150mg	150mg	Tablet, film coated	564,414 L.L
L01EF01	IBRANCE	B	Palbociclib - 75mg	75mg	Tablet, film coated	172,164,216 L.L
C09CA04	IBECARD 300- IPS	G	Irbesartan - 300mg	300mg	Tablet, film coated	564,414 L.L
C09CA04	IRBAVEL 300	G	Irbesartan - 300mg	300mg	Tablet, film coated	564,414 L.L
L01EF01	IBRANCE	B	Palbociclib - 100mg	100mg	Tablet, film coated	172,164,216 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Tablet, film coated	172,164,216 L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 420mg	420mg	Tablet, film coated	L.L
J01MA12	ILFLOX	G	Levofloxacin - 500mg	500mg	Tablet, film coated	587,259 L.L
L04AA06	IMUNOCELL	G	Mycophenolate mofetil - 500mg	500mg	Tablet, film coated	3,791,428 L.L
L01EK01	INLYTA	B	Axitinib - 5mg	5mg	Tablet, film coated	184,486,511 L.L
L01EK01	INLYTA	B	Axitinib - 1mg	1mg	Tablet, film coated	57,595,789 L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 140mg	140mg	Tablet, film coated	194,761,420 L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 420mg	420mg	Tablet, film coated	584,283,050 L.L
M01AE51	IBUGESIC COLD AND SINUS	G	Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg		Tablet, film coated	154,542 L.L
C09DA04	IBECARD PLUS 150/12.5	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	559,294 L.L
C09DA04	IRBAVEL PLUS 150/12.5	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	559,294 L.L
C09DA04	IBECARD PLUS 300/12.5	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	559,294 L.L
C09DA04	IRBAVEL PLUS 300/12.5	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	559,294 L.L
C09DA04	IBECARD PLUS 300/25	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	624,567 L.L
C09DA04	IRBAVEL PLUS 300/25	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	624,567 L.L
C08DA01	ISOPTIN	B	Verapamil (HCl) - 80mg	80mg	Tablet, film coated	397,704 L.L
A10BD09	INCRESYNC	B	Pioglitazone - 15mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
A10BD09	INCRESYNC	B	Pioglitazone - 30mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
A10BD11	INAGLIMET	G	Metformin - 1000mg, Linagliptin - 2.5mg		Tablet, film coated	1,670,844 L.L
A10BD11	INAGLIMET	G	Metformin - 850mg, Linagliptin - 2.5mg		Tablet, film coated	1,670,844 L.L